Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Raymond Linovitz

Orthopaedic Surgery of the Spine Encinitas, CA Medical Doctor

NPI 1912090853 CMS profile 86537

332 Santa Fe Dr, Suite 110, Encinitas, CA 92024

Open in the dashboard

General payments

$92,355

86 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Raymond Linovitz of Encinitas, CA is reported in the CMS Open Payments database as having received $92,355 across 86 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,925 16
2024 General $25,581 19
2023 General $5,808 12
2022 General $5,784 9
2021 General $5,898 8
2020 General $10,931 8
2019 General $27,427 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Raymond Linovitz
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Raymond Linovitz were reported at $10,925. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Raymond Linovitz Orthopaedic Surgery of the Spine median Middle half National median
2019 $27,427 $2,106 $337–$18,608 $163
2020 $10,931 $1,213 $156–$15,082 $114
2021 $5,898 $1,834 $271–$15,617 $132
2022 $5,784 $2,015 $320–$17,036 $149
2023 $5,808 $1,925 $336–$14,599 $160
2024 $25,581 $2,110 $341–$12,483 $164
2025 $10,925 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Orthofix Medical, Inc. $62,254 71 payments
  2. Extremity Medical $27,601 14 payments
  3. Spinal Elements, Inc. $2,500 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $52,126 66 payments
  2. Consulting Fee $31,150 8 payments
  3. Travel and Lodging $9,079 12 payments
Products named General payments · program years 2019–2025
  1. Ascent LE Posterior Occipital Cervico-Thoracic System $20,857 12 payments
  2. NGage Surgical Mesh System $19,673 12 payments
  3. Neo MTX $18,750 3 payments
  4. M6-C Artificial Cervical Disc $9,578 3 payments
  5. Ngage Device $6,243 8 payments
  6. ASCENT LE;CENTURION;FIREBIRD SFS $6,114 7 payments
  7. NGAGE Spinal Vertebral Body Replacement Device $5,210 8 payments
  8. Physio-Stim $5,073 10 payments
  9. Ascent $3,398 15 payments
  10. Karma $2,500 1 payment
  11. Other $2,009 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Orthopaedic Surgery: 30

Drug cost

$0

Median for Orthopaedic Surgery: $176

Branded share of claims

0%

Median for Orthopaedic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Alprazolam Generic 12 $0

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,233 Part D prescribers listed as Orthopaedic Surgery; they describe a distribution and say nothing about conduct.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record